Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Altarex receives funding for photodynamic therapy for ovarian cancer research

April 28, 1997

No Comments

Bioniche reports positive clinical results for Regressin

April 25, 1997

No Comments

BTG licenses Campath-1H to LeukoSite

April 25, 1997

No Comments

Cel-Sci initiates clinical trial of Multikine in Israel

April 24, 1997

No Comments

Medarex presents MDX-220 preclinical data at AACR

April 21, 1997

No Comments

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

No Comments

Antitumor activity of Ono-4007 related to TNF induction

April 7, 1997

No Comments

CAT and Techniclone to initiate trials for tumor therapy

March 27, 1997

No Comments

Bristol-Myers Squibb discovers new ribosome-inactivating protein

March 27, 1997

No Comments

Multikine trial approved in Israel

March 21, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immuno-oncology, BioWorld Science
RSS

Altarex receives funding for photodynamic therapy for ovarian cancer research

Bioniche reports positive clinical results for Regressin

BTG licenses Campath-1H to LeukoSite

Cel-Sci initiates clinical trial of Multikine in Israel

Medarex presents MDX-220 preclinical data at AACR

Supplemental BLA submitted in U.S. for Proleukin

Antitumor activity of Ono-4007 related to TNF induction

CAT and Techniclone to initiate trials for tumor therapy

Bristol-Myers Squibb discovers new ribosome-inactivating protein

Multikine trial approved in Israel

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Immuno-oncology, BioWorld Science RSS

Immuno-oncology, BioWorld Science
RSS